¡Ya estamos en !
Descubre más
CNCE
Concert Pharmaceuticals, Inc.
Excluida de cotización
CNCE dejó de cotizar en bolsa el 3 de marzo de 2023.
Acerca de: Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the currently approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.
Empleados: 64
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
No hemos recibido artículos de noticias recientes sobre CNCE.
Gráficos de precios implementados con Lightweight Charts™